Literature DB >> 3022973

Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection.

N T Ilowite, C L Fligner, H D Ochs, B Brichacek, S Harada, J E Haas, D T Purtilo, R J Wedgwood.   

Abstract

We describe a 12-year-old boy with Wiskott-Aldrich syndrome who developed a pulmonary vasculitis associated with lymphoreticular proliferation, consistent with the histological and clinical diagnosis of lymphomatoid granulomatosis. The lesions were responsive to cyclophosphamide and steroids. The patient has had severely depressed immune function and was shown to have abnormal Epstein-Barr virus (EBV)-specific cellular and humoral immune responses. Lymph nodes obtained at autopsy were positive for EBV genome. In this patient, reactivated EBV infection resulting from impaired immune surveillance of the virus may have been responsible for the development of this paraneoplastic disorder.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022973     DOI: 10.1016/0090-1229(86)90018-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  MR imaging of the brain in lymphomatoid granulomatosis.

Authors:  U Tateishi; S Terae; A Ogata; Y Sawamura; Y Suzuki; S Abe; K Miyasaka
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

Review 2.  Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Authors:  Ethel Cesarman
Journal:  Cancer Lett       Date:  2011-04-13       Impact factor: 8.679

3.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Systemic vasculitis and aneurysm formation in the Wiskott-Aldrich syndrome.

Authors:  W G McCluggage; D J Armstrong; R J Maxwell; P K Ellis; D R McCluskey
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.